FAP and neoplasm: In contrast, we detected many GFP+ FAP-CAR T cells infiltrating into the tumors, which diminished both FAP+ stromal cells and PanCK+ tumor cells (Fig. 2h), further validating the robust anti-tumor activity of FAP-CAR T cells in this autochthonous PDAC model.